Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Plasma Cell 1 Glioblastoma 1

Interventions

Radiotherapy 3 Temozolomide 2 pembrolizumab 1 ipatasertib 1 dactolisib 1 Zinc 1 Metformin 1 Lomustine 1 Hypoglycemic Agents 1 Duloxetine Hydrochloride 1 Diet, Carbohydrate-Restricted 1 Biguanides 1 Atorvastatin 1 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Glioblastoma × Atorvastatin × Clear all

NCT02029573 2017-08-18

ART

King Fahad Medical City

Phase 2 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡